Faricimab treatment outcomes with extended dosing and potential for Q20W intervals in DME: post hoc analysis of the 96-week phase 3 YOSEMITE/RHINE trials Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Adam, Murtaza K
  • Gibson, Kara
  • Sim, Dawn
  • Amador, Manuel
  • Hill, Lauren
  • Singer, Michael

publication date

  • June 2024